Nanobiotix is trading at $38.55 (+5.21%) with no clear company-specific catalyst identified for September 10, 2026.
- Nanobiotix announced participation in an H.C. Wainwright fireside chat scheduled for September 15, but the release provided no new operating or clinical update.
- Broader markets are declining amid hotter PPI data and rate-cut concerns, though Nanobiotix is moving in the opposite direction.